
Clinical Updatesrisk stratificationCost-Effectiveness
Standalone Salpingectomy for Primary Ovarian Cancer Prevention: A Cost-Effectiveness Analysis
By MedXY|Sep 23, 2026
This review synthesizes evidence on the cost-effectiveness of standalone salpingectomy for ovarian cancer prevention, highlighting its benefits primarily in women at moderately elevated risk, especially between ages 45-50, supporting tailor
